Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia

Autor: Yvonne Schönbeck, Annelieke A A van der Linde, Paul H. Verkerk, Roelof Odink, Hedi L Claahsen-van der Grinten, Paul van Trotsenburg, Mirjam E. van Albada, Anita Boelen, Peter C. J. I. Schielen, Saartje Straetemans, Martijn J. J. Finken, Erica L T van den Akker, Hetty J. van der Kamp, Gera Hoorweg-Nijman, Sabine E. Hannema

Publikováno v: Archives of Disease in Childhood, 104(7), 653-657. BMJ Publishing Group
Archives of Disease in Childhood, 104, 653-657
Archives of Disease in Childhood, 104(7), 653-657. BMJ PUBLISHING GROUP
Archives of Disease in Childhood, 104(7), 653. BMJ Publishing Group
Archives of Disease in Childhood, 104, 7, pp. 653-657
Archives of disease in childhood, 104(7), 653-657. BMJ Publishing Group
van der Linde, A A A, Schönbeck, Y, van der Kamp, H J, van den Akker, E L T, van Albada, M E, Boelen, A, Finken, M J J, Hannema, S E, Hoorweg-Nijman, G, Odink, R J, Schielen, P C J I, Straetemans, S, van Trotsenburg, P S, Claahsen-van der Grinten, H L & Verkerk, P H 2019, ' Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia ', Archives of Disease in Childhood, vol. 104, no. 7, pp. 653-657 . https://doi.org/10.1136/archdischild-2018-315972, https://doi.org/10.1136/archdischild-2018-315972
Archives of Disease in Childhood, 7, 104, 653-657
Archives of Disease in Childhood, 104(7), 653-657

BackgroundIn 2002, a nationwide screening for congenital adrenal hyperplasia (CAH) was introduced in the Netherlands. The aim of our study is to evaluate the validity of the neonatal screening for CAH and to assess how many newborns with salt-wasting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f84b09644338ab6d7cec9767921320
http://hdl.handle.net/10029/622765

Behavioral Problems and Depressive Symptoms in Adolescents with Type 1 Diabetes Mellitus: Self and Parent Reports

Autor: Angelique B. C. Roeleveld-Versteegh, Roelof Odink, Nienke M. Maas-van Schaaijk, Anneloes L. van Baar

© 2013 Maasvan Schaaijk et al., licensee InTech. This is an open access chapter distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0001d8b6c5b0f84873f047589ae9129c
https://doi.org/10.5772/50667

Homozygosity for a FBN1 missense mutation: clinical and molecular evidence for recessive Marfan syndrome

Autor: Bert B.A. de Vries, Roelof Odink, Ben C.J. Hamel, Gerard Pals

Publikováno v: European Journal of Human Genetics, 15, 930-5
European Journal of Human Genetics, 15, 9, pp. 930-5

Marfan syndrome (MFS) is known as an autosomal-dominant connective tissue disorder (MIM 154,700), involving primarily the skeletal, ocular and cardiovascular systems, and caused by mutations in the gene for fibrillin1 (FBN1). Here, we report on two c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a0f33246a92ec1b98383427eb595ed
https://pubmed.ncbi.nlm.nih.gov/17568394

PS11 - 59. Development of a new observational rating scale to measure the quality of parent-child interactions in young children with type 1 diabetes mellitus

Autor: Hedwig J.A. van Bakel, Wilco H. M. Emons, Henk-Jan Aanstoot, Anke M. Nieuwesteeg, Roelof Odink, Frans Pouwer, Esther Hartman

Publikováno v: Nederlands Tijdschrift voor Diabetologie. 9:131-131

In young children (0-7 years) with diabetes mellitus type 1 (T1DM), parents have full responsibility for the diabetesmanagement of their child. The tasks needed to achieve optimal blood glucose control may interfere with normal behavioral processes i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4cc7037e18079bb089b406dfd6721863
https://doi.org/10.1007/s12467-011-0084-6